机构

• 上海药物研究所 [10]
• 合肥物质科学研究院 [2]
• 上海营养与健康研究所 [1]

采集方式

• OAI收割 [13]

内容类型

• 期刊论文 [13]

发表日期

• 2023 [2]
• 2022 [1]
• 2021 [4]
• 2020 [2]
• 2019 [2]
• 2018 [1]
• 更多

学科主题

• Biochemist... [1]
• Biophysics [1]

筛选

浏览/检索结果: 共13条，第1-10条 帮助 条数/页： 5101520253035404550556065707580859095100 排序方式： 请选择提交时间升序提交时间降序发表日期升序发表日期降序题名升序题名降序作者升序作者降序 Degradation of Cyclin-Dependent Kinase 9/Cyclin T1 by Optimized Microtubule-Associated Protein 1 Light Chain 3 Beta-Recruiting Coumarin Analogs 期刊论文  OAI收割 JOURNAL OF MEDICINAL CHEMISTRY, 2023, 页码: 17 作者:  Zeng, Yanping;  Xiao, Jian;  Xu, Yuanxin;  Wei, Fan;  Tian, Lina   |  收藏  |  浏览/下载：7/0  |  提交时间：2023/10/17 Predicting and overcoming resistance to CDK9 inhibitors for cancer therapy 期刊论文  OAI收割 ACTA PHARMACEUTICA SINICA B, 2023, 卷号: 13 作者:  Hua, Chen;  Shena, Lijuan;  Zoua, Fengming;  Wua, Yun;  Wanga, Beilei   |  收藏  |  浏览/下载：11/0  |  提交时间：2023/11/10 Acquired resistance mutations  CDK9 inhibitors  Transcription  Single nucleotide polymorphisms  BAY1251152   CDK9 inhibitors in cancer research 期刊论文  OAI收割 RSC MEDICINAL CHEMISTRY, 2022 作者:  Huang, Zhi;  Wang, Tianqi;  Wang, Cheng;  Fan, Yan   |  收藏  |  浏览/下载：10/0  |  提交时间：2022/12/23 Discovery of Potent and Selective CDK9 Degraders for Targeting Transcription Regulation in Triple-Negative Breast Cancer 期刊论文  OAI收割 JOURNAL OF MEDICINAL CHEMISTRY, 2021, 卷号: 64, 期号: 19, 页码: 14822-14847 作者:  Wei, Dan;  Wang, Hanlin;  Zeng, Qinghe;  Wang, Wenjing;  Hao, Bingbing   |  收藏  |  浏览/下载：45/0  |  提交时间：2021/12/16 Rational Design and Development of Novel CDK9 Inhibitors for the Treatment of Acute Myeloid Leukemia 期刊论文  OAI收割 JOURNAL OF MEDICINAL CHEMISTRY, 2021, 卷号: 64, 期号: 19, 页码: 14647-14663 作者:  Han, Xu;  Song, Ning;  Saidahmatov, Abdusaid;  Wang, Peipei;  Wang, Yong   |  收藏  |  浏览/下载：58/0  |  提交时间：2021/12/16 Efficient Synthesis and Docking Analysis of Selective CDK9 Inhibitor NVP-2 期刊论文  OAI收割 Pharmaceutical Fronts, 2021, 期号: 3, 页码: E50-E55 作者:  Saidahmatov, Abdusaid;  Liang, Xue-Wu;  Shi, Yuqiang;  Han, Xu;  Liu, Hong   |  收藏  |  浏览/下载：8/0  |  提交时间：2024/03/14 NVP-2  CDK9 inhitor  efficient synthesis  docking analysis   Discovery of selective CDK9 degraders with enhancing antiproliferative activity through PROTAC conversion 期刊论文  OAI收割 EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2021, 卷号: 211, 页码: 11 作者:  Qiu, Xiaqiu;  Li, Yuanqing;  Yu, Bin;  Ren, Jie;  Huang, Huidan   |  收藏  |  浏览/下载：24/0  |  提交时间：2021/05/24 CDK9  Antitumor  PROTAC  AML  Degrader   Rational Design and Evaluation of 6-(Pyrimidin-2-ylamino)-3,4-dihydroquinoxalin-2(1H)-ones as Polypharmacological Inhibitors of BET and Kinases 期刊论文  OAI收割 JOURNAL OF MEDICINAL CHEMISTRY, 2020, 卷号: 63, 期号: 17, 页码: 9787-9802 作者:  Lv, Kaikai;  Chen, Weicong;  Chen, Danqi;  Mou, Jie;  Zhang, Huijie   |  收藏  |  浏览/下载：22/0  |  提交时间：2020/12/21 EZH2 inhibitors abrogate upregulation of trimethylation of H3K27 by CDK9 inhibitors and potentiate its activity against diffuse large B-cell lymphoma 期刊论文  OAI收割 HAEMATOLOGICA, 2020, 卷号: 105, 期号: 4, 页码: 1021-1031 作者:  Xie, Shao;  Wei, Fan;  Sun, Yi-ming;  Gao, Ying-lei;  Pan, Lu-lu   |  收藏  |  浏览/下载：27/0  |  提交时间：2020/07/01 Design of wogonin-inspired selective cyclin-dependent kinase 9 (CDK9) inhibitors with potent in vitro and in vivo antitumor activity 期刊论文  OAI收割 EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2019, 卷号: 178, 页码: 782-801 作者:  Wang, Jubo;  Li, Tinghan;  Zhao, Tengteng;  Wu, Tizhi;  Liu, Chuang   |  收藏  |  浏览/下载：17/0  |  提交时间：2020/07/01 Wogonin  CDK9  AML  Flavonoid  Antitumor